Atara Biotherapeutics
ATRA
ATRA
70 hedge funds and large institutions have $374M invested in Atara Biotherapeutics in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
74% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 19
Holders
70
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$14.1M | |
| 2 | +$6.08M | |
| 3 | +$3.28M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.16M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.05M |
Top Sellers
| 1 | -$6.37M | |
| 2 | -$2.54M | |
| 3 | -$2.51M | |
| 4 |
Morgan Stanley
New York
|
-$2.28M |
| 5 |
VAM
Visium Asset Management
New York
|
-$2.22M |